SEC Form 4 · accession 0001209191-15-015878
NANOPHASE TECHNOLOGIES Corp · NANX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A McClung
Director
Period of report
Feb 18, 2015
Accepted (ET)
Feb 19, 2015 · 1:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000883107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 30,071 | I | By Wife | |
| Common Stock | holding | — | — | — | 17,582 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F7 | $0.44 | Feb 18, 2015 | A | 10,800 | A | Feb 18, 2016 | Feb 18, 2025 | Common Stock | 10,800 | 10,800 | D |
| Stock Option (right to buy)F1 | $1.36 | holding | — | — | — | Jan 31, 2012 | Jan 31, 2021 | Common Stock | 12,000 | 12,000 | D |
| Deferred Common StockF2,F3,F4 | — | holding | — | — | — | — | — | Common Stock | 2,250 | 21,596 | D |
| Stock Appreciation RightF5 | $0.99 | holding | — | — | — | — | — | Common Stock | 2,250 | 15,750 | D |
| Stock Option (right to buy)F1 | $0.30 | holding | — | — | — | Aug 7, 2013 | Aug 7, 2022 | Common Stock | 12,000 | 12,000 | D |
| Stock Option (right to buy)F1 | $0.415 | holding | — | — | — | Feb 14, 2014 | Feb 14, 2023 | Common Stock | 12,000 | 12,000 | D |
| Stock Option (right to buy)F6 | $0.52 | holding | — | — | — | Feb 13, 2015 | Feb 13, 2024 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments.
- F2Each share of deferred common stock represents a right to receive one share of common stock.
- F3The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
- F4Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 21,596 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
- F5The stock appreciation right becomes payable upon the reporting person's termination of service as a director of the Company. 2,250 were issued 4/8/2009 at a conversion price of $0.90, 2,250 were issued 7/1/2009 at a conversion price of $1.05, 2,250 were issued 10/1/2009 at a conversion price of $1.18, 2,250 were issued 1/4/2010 at a conversion price of $0.84, 2,250 were issued 4/1/2010 at a conversion price of $1.85, 2,250 were issued 7/1/2010 at a conversion price of $1.10, and 2,250 were issued 10/1/2010 at a conversion price of $0.99.
- F6Beginning on this date, and subject to certain restrictions, the stock options vest in three equal annual installments.
- F7Beginning on this date, and subject to certain restrictions, options vest in three equal annual installments.